Akebia Therapeutics Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Akebia Therapeutics stock downgraded to Sell Candidate
(Updated on Apr 17, 2024)
The Akebia Therapeutics stock price fell by -0.714% on the last day (Wednesday, 17th Apr 2024) from $1.40 to $1.39. During the last trading day the stock fluctuated 4.41% from a day low at $1.36 to a day high of $1.42. The price has been going up and down for this period, and there has been a -6.71% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 3 million shares were bought and sold for approximately $4.01 million.
The stock has broken the very wide and weak rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $1.39. A reaction back to this level may hold a second chance to get out before further falls.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
AKBA Signals & Forecast
A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Akebia Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.47 and $1.64. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Akebia Therapeutics stock
Akebia Therapeutics finds support from accumulated volume at $1.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0600 between high and low, or 4.41%. For the last week, the stock has had daily average volatility of 6.04%.
Akebia Therapeutics is oversold on RSI14 (10). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (AKBA) For The Upcoming Trading Day Of Thursday 18th
For the upcoming trading day on Thursday, 18th we expect Akebia Therapeutics to open at $1.39, and during the day (based on 14 day Average True Range), to move between $1.24 and $1.54, which gives a possible trading interval of +/-$0.154 (+/-11.11%) up or down from last closing price. If Akebia Therapeutics takes out the full calculated possible swing range there will be an estimated 22.23% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $1.37 (1.44%) than the resistance at $1.49 (7.19%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Akebia Therapeutics stock A Buy?
The Akebia Therapeutics stock holds several negative signals and despite the positive trend, we believe Akebia Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -2.916 Sell Candidate Downgraded
Predicted Opening Price for Akebia Therapeutics of Thursday, April 18, 2024
| Fair opening price April 18, 2024 | Current price |
|---|---|
| $1.39 ( 0%) | $1.39 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for AKBA
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.45 | 4.32 % | |
| R2 | 1.43 | 2.67 % | ||
| R1 | 1.41 | 1.65 % | ||
| Current price: | 1.39 | |||
| Support | S1 | 1.37 | -1.65 % | |
| S2 | 1.35 | -2.67 % | ||
| S3 | 1.33 | -4.32 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 1.70 | 22.30 % | |
| R2 | 1.63 | 17.27 % | ||
| R1 | 1.49 | 7.19 % | ||
| Current price | 1.39 | |||
| Support | S1 | 1.37 | -1.44% | |
| S2 | 1.35 | -2.88% | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy Akebia Therapeutics Stock.
